237 related articles for article (PubMed ID: 31896113)
21. Sirolimus Treatment of an Infant With Intrathoracic Kaposiform Hemangioendothelioma Complicated by Life-threatening Pleural and Pericardial Effusions.
Duan L; Renzi S; Weidman D; Waespe N; Chami R; Manson D; Cada M; Carcao M
J Pediatr Hematol Oncol; 2020 Jan; 42(1):74-78. PubMed ID: 30044355
[TBL] [Abstract][Full Text] [Related]
22. Usefulness of D2-40 immunohistochemistry for differentiation between kaposiform hemangioendothelioma and tufted angioma.
Arai E; Kuramochi A; Tsuchida T; Tsuneyoshi M; Kage M; Fukunaga M; Ito T; Tada T; Izumi M; Shimizu K; Hirose T; Shimizu M
J Cutan Pathol; 2006 Jul; 33(7):492-7. PubMed ID: 16872472
[TBL] [Abstract][Full Text] [Related]
23. Laryngomalacia and complicated, life-threatening mTOR-positive Kaposiform hemangioendothelioma cured by Supraglottoplasty and sirolimus.
Schroeder U; Lauten M; Stichtenoth G; Gebhard MP; Buchholz M; Kaiser MM
Klin Padiatr; 2014 Nov; 226(6-7):362-8. PubMed ID: 24810750
[TBL] [Abstract][Full Text] [Related]
24. Decreased vascularization of retroperitoneal kaposiform hemangioendothelioma induced by treatment with sirolimus explains relief of symptoms.
Iacobas I; Simon ML; Amir T; Gribbin CE; McPartland TG; Kaufman MR; Calderwood S; Nosher JL
Clin Imaging; 2015; 39(3):529-32. PubMed ID: 25662209
[TBL] [Abstract][Full Text] [Related]
25. Steroid-resistant kaposiform hemangioendothelioma: a retrospective study of 37 patients treated with vincristine and long-term follow-up.
Wang Z; Li K; Yao W; Dong K; Xiao X; Zheng S
Pediatr Blood Cancer; 2015 Apr; 62(4):577-80. PubMed ID: 25346262
[TBL] [Abstract][Full Text] [Related]
26. Kaposiform haemangioendothelioma: a review with emphasis on histological differential diagnosis.
Putra J; Gupta A
Pathology; 2017 Jun; 49(4):356-362. PubMed ID: 28438388
[TBL] [Abstract][Full Text] [Related]
27. Treatment practices and response in kaposiform hemangioendothelioma: A multicenter cohort study.
Borst AJ; Eng W; Griffin M; Ricci KW; Engel E; Adams DM; Dayneka J; Cohen-Cutler SJ; Andreoli SM; Wu MD; Wheeler AP; Heym KM; Crary SE; Nakano TA; Schulte RR; Setty BA; McLean TW; Pahl KS; Intzes S; Pateva I; Teitelbaum M; Zong Z; Li Y; Jeng MR
Pediatr Blood Cancer; 2024 Mar; 71(3):e30779. PubMed ID: 38073018
[TBL] [Abstract][Full Text] [Related]
28. Medical management of tumors associated with Kasabach-Merritt phenomenon: an expert survey.
Tlougan BE; Lee MT; Drolet BA; Frieden IJ; Adams DM; Garzon MC
J Pediatr Hematol Oncol; 2013 Nov; 35(8):618-22. PubMed ID: 23774156
[TBL] [Abstract][Full Text] [Related]
29. Vincristine and sirolimus in the treatment of kaposiform haemangioendothelioma.
Peng S; Yang K; Xu Z; Chen S; Ji Y
J Paediatr Child Health; 2019 Sep; 55(9):1119-1124. PubMed ID: 30604513
[TBL] [Abstract][Full Text] [Related]
30. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon in an infant: Successful treatment with prednisolone, vincristine, and addition of sirolimus.
Cashell J; Smink GM; Helm K; Xavier F
Pediatr Blood Cancer; 2018 Dec; 65(12):e27305. PubMed ID: 30070028
[TBL] [Abstract][Full Text] [Related]
31. Treatment of kaposiform hemangioendothelioma and tufted angioma.
Liu XH; Li JY; Qu XH; Yan WL; Zhang L; Yang C; Zheng JW
Int J Cancer; 2016 Oct; 139(7):1658-66. PubMed ID: 27252149
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathological features of Kaposiform hemangioendothelioma.
Liu Q; Jiang L; Wu D; Kan Y; Fu F; Zhang D; Gong Y; Wang Y; Dong C; Kong L
Int J Clin Exp Pathol; 2015; 8(10):13711-8. PubMed ID: 26722599
[TBL] [Abstract][Full Text] [Related]
33. Comparison of efficacy and safety of corticosteroid and vincristine in treating kaposiform hemangioendothelioma and tufted angioma: A multicenter prospective randomized controlled clinical trial.
Yao W; Li K; Wang Z; Wang J; Ji Y; Zhou L; Huang H; Gao X; Huang Z; Gu S; Yang H; Zheng S
J Dermatol; 2021 May; 48(5):576-584. PubMed ID: 33608936
[TBL] [Abstract][Full Text] [Related]
34. A Case Report of 2 Sirolimus-Related Deaths Among Infants With Kaposiform Hemangioendotheliomas.
Ying H; Qiao C; Yang X; Lin X
Pediatrics; 2018 Apr; 141(Suppl 5):S425-S429. PubMed ID: 29610165
[TBL] [Abstract][Full Text] [Related]
35. Comparison of Corticosteroid and Vincristine in Treating Kaposiform Hemangioendothelioma and Tufted Angioma: A Systematic Review and Meta-Analysis.
Yao W; Li K; Wang Z; Pei J; Liu X; Zheng S; Dong K
Eur J Pediatr Surg; 2019 Oct; 29(5):401-407. PubMed ID: 30372769
[TBL] [Abstract][Full Text] [Related]
36. Restricted Range of Motion and a Cold Upper Extremity in a Two-Year-Old Boy: Kaposiform Hemangioendothelioma of the Bone and the Brachial Plexus: A Case Report.
Patel S; Kamath S; Shillingford NM; Zeinati C; Tolo V; Luu M
JBJS Case Connect; 2017; 7(4):e79. PubMed ID: 29286963
[TBL] [Abstract][Full Text] [Related]
37. First Intracardiac Kaposiform Hemangioendothelioma in an Infant Resolved With Sirolimus: A Case Report.
Zaidi SJ; Shaik S; Agrawal C; Cossor W
J Pediatr Hematol Oncol; 2018 Oct; 40(7):536-540. PubMed ID: 30067556
[TBL] [Abstract][Full Text] [Related]
38. Clinical Outcomes for Systemic Corticosteroids Versus Vincristine in Treating Kaposiform Hemangioendothelioma and Tufted Angioma.
Liu X; Li J; Qu X; Yan W; Zhang L; Zhang S; Yang C; Zheng J
Medicine (Baltimore); 2016 May; 95(20):e3431. PubMed ID: 27196448
[TBL] [Abstract][Full Text] [Related]
39. Low dose sirolimus treatment for refractory tufted angioma and congenital kaposiform hemangioendothelioma, both with Kasabach-Merritt phenomenon.
Mariani LG; Schmitt IR; Garcia CD; Kiszewski AE
Pediatr Blood Cancer; 2019 Aug; 66(8):e27810. PubMed ID: 31087627
[No Abstract] [Full Text] [Related]
40. Management of Refractory Pediatric Kaposiform Hemangioendothelioma With Sirolimus and Aspirin.
MacFarland SP; Sullivan LM; States LJ; Bailey LC; Balamuth NJ; Womer RB; Olson TS
J Pediatr Hematol Oncol; 2018 May; 40(4):e239-e242. PubMed ID: 29240034
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
